Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Another market introduction for cidofovir

June 25, 1998

Nabi licenses technology for development of antiviral drug

June 24, 1998

Substituted carbapenems for Gram-positive infections designed at Merck & Co.

June 24, 1998

Abbott patents improved ketolide antibacterial agents

June 24, 1998

Nyotran compared to free nystatin and amphotericin B formulations in vitro

June 23, 1998

FDA approves biotech product for RSV disease in children

June 22, 1998

New macrolide antibiotic derivatives from Pfizer

June 22, 1998

Novel trpS polypeptides/polynucleotides for the treatment of bacterial infections

June 19, 1998

Famvir cleared by FDA for treatment of herpes in HIV-positive individuals

June 18, 1998

Potent in vivo antifungal activity of cordycepin in combination with ADA inhibitor

June 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...